Core Viewpoint - The announcement by健世科技-B (09877.HK) highlights the results of several clinical trials related to their cardiovascular systems, showcasing advancements in minimally invasive heart valve procedures [1] Group 1: Clinical Trial Results - The global multicenter clinical trial "TRINITY" for the LuX-Valve Plus transcatheter tricuspid valve replacement (TTVR) system has reported six-month follow-up results [1] - The one-year follow-up results for the JensClip transcatheter mitral valve repair (TMVr) system and its application in challenging cases were presented [1] - The one-year follow-up results for the Ken-Valve transcatheter aortic valve replacement (TAVR) system and its performance in challenging cases were also shared [1] Group 2: Event Details - The results were presented at the TCT 2025 conference held in San Francisco, USA [1]